Description
Seeking boys aged 2 and older with Duchenne Muscular Dystrophy who have been prescribed Vamorolone (Agamree) for a study of the long-term safety of the drug.
Overview
Participants in this study will have 5 study visits over 5 years and will be asked to complete questionnaires every year.
What we're hoping for
We are studying the long-term safety of the drug Vamorolone (Agamree) prescribed for boys aged 2 and older with Duchenne Muscular Dystrophy.
Additional Information
ClinicalTrials.gov Identifier: Not Available